Merck on Friday said the recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use covers the 21-valent conjugate vaccine for immunization for the prevention ...
Biogen (NASDAQ:BIIB) and Eisai (OTCPK:ESALF) are expected to face another delay in launching their new Alzheimer's drug, lecanemab, in the EU after the European Commission on Friday asked the region's ...
The European medicines regulator said on Friday it will review safety information for Eisai and Biogen's Leqembi that the ...
In recognition of Change Your Password Day, Keeper Security, the leading cybersecurity provider of zero-trust and zero-knowledge Privileged Access Management (PAM) software protecting passwords, ...